Latest Insider Transactions at Syros Pharmaceuticals, Inc. (SYRS)
This section provides a real-time view of insider transactions for Syros Pharmaceuticals, Inc. (SYRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syros Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syros Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2021
|
Eric R Olson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,164
-100.0%
|
$5,820
$5.55 P/Share
|
|
Mar 15
2021
|
Eric R Olson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,628
-100.0%
|
$32,652
$9.47 P/Share
|
|
Mar 15
2021
|
Eric R Olson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,628
+50.0%
|
$3,628
$1.01 P/Share
|
|
Feb 16
2021
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
3,750
-1.15%
|
$45,000
$12.05 P/Share
|
|
Feb 08
2021
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
3,750
-1.14%
|
$48,750
$13.04 P/Share
|
|
Dec 18
2020
|
Nancy A Simonian |
BUY
Exercise of conversion of derivative security
|
Direct |
29,917
+1.76%
|
$209,419
$7.21 P/Share
|
|
Dec 08
2020
|
Srinivas Akkaraju |
BUY
Grant, award, or other acquisition
|
Indirect |
625,000
+24.76%
|
-
|
|
Nov 17
2020
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
5,357
-1.55%
|
$42,856
$8.75 P/Share
|
|
Nov 16
2020
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
633
-0.18%
|
$5,064
$8.98 P/Share
|
|
Oct 19
2020
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
5,673
-1.66%
|
$45,384
$8.75 P/Share
|
|
Oct 15
2020
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
317
-0.09%
|
$2,536
$8.75 P/Share
|